Marc Grasso
Chief Financial Officer · Kyverna Therapeutics, Inc.
- 2024
- Mar 17, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Marc Grasso files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Arnon Rosenthal - $656K in ALEC purchases and sales in the last 12 months
- Karen Marie Walker - $293K in KYTX purchases and sales in the last 12 months
- Neil Lindsay Berkley - $221K in ALEC purchases and sales in the last 12 months
- Grace Wong-Sarad - $86K in ALEC purchases and sales in the last 12 months
- Sara Kenkare-Mitra - $47K in ALEC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Marc Grasso?
Marc Grasso is a corporate insider, tracked as Chief Financial Officer of Kyverna Therapeutics, Inc. (KYTX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Marc Grasso last file a Form 4?
The most recent primary Form 4 on record is dated 17 March 2026, one of 4 filings going back to 2024.
Has Marc Grasso been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($42K) across all tracked filings.
